Prognostic Significance of Myocardial Ischemia Detected by Ambulatory Electrocardiography, Exercise Treadmill Testing, and Electrocardiogram at Rest to Predict Cardiac Events by One Year (The Asymptomatic Cardiac Ischemia Pilot [ACIP] Study)

• Published in: The American journal of cardiology 1997-12, Vol.80 (11), p.1395-1401
• Main Authors: Stone, Peter H., Chaitman, Bernard R., Forman, Sandra, Andrews, Thomas C., Bittner, Vera, Bourassa, Martial G., Davies, Richard F., Deanfield, John E., Frishman, William, Goldberg, A.David, MacCallum, Gail, Ouyang, Pamela, Pepine, Carl J., Pratt, Craig M., Sharaf, Barry, Steingart, Richard, Knatterud, Genell L., Sopko, George, Conti, C.Richard
• Format: Article
• Language: English
• Subjects: Biological and medical sciences; Cardiology. Vascular system; Coronary heart disease; Electrocardiography; Electrocardiography, Ambulatory - methods; Exercise Test; Female; Follow-Up Studies; Heart; Humans; Male; Medical sciences; Middle Aged; Multivariate Analysis; Myocardial Ischemia - diagnosis; Myocardial Ischemia - physiopathology; Myocardial Ischemia - therapy; Myocardial Revascularization; Pilot Projects; Predictive Value of Tests; Prognosis; Rest - physiology; Vasodilator Agents - therapeutic use
• ISSN: 0002-9149; 1879-1913
• DOI: 10.1016/S0002-9149(97)00706-6

Myocardial ischemia identified by ambulatory electrocardiography (AECG), exercising treadmill testing, (ETT), or 12-lead electrocardiogram at rest is associated with an adverse prognosis, but the effect of improving these ischemic manifestations by treatment on outcome is unknown. The Asymptomatic Cardiac Ischemia Pilot (ACIP) study was a National Heart, Lung, and Blood Institute funded study to determine the feasibility of conducting a large-scale prognosis study and to assess the effect of 3 treatment strategies (angina-guided strategy, AECG ischemia-guided strategy, and revascularization strategy) in reducing the manifestations of ischemia as indicated by AECG and ETT. The study cohort for this database study consisted of 496 randomized patients who performed the AECG, ETT, and 12-lead electrocardiogram at rest at both the qualifying and week 12 visits. The effect of modifying ischemia by treatment on the incidence of cardiac events (death, myocardial infarction, coronary revascularization procedure, or hospitalization for an ischemic event) at 1 year was examined. In the 2 medical treatment groups (n = 328) there was an association between the number of ambulatory electrocardiographic ischemic episodes at the qualifying visit and combined cardiac events at 1 year (p = 0.003). In the AECG ischemia-guided patients there was a trend associating greater reduction in the number of ambulatory electrocardiographic ischemia episodes with a reduced incidence of combined cardiac events (r = −0.15, p = 0.06). In the revascularization strategy patients this association was absent. In the medical treatment patients the exercise duration on the baseline ETT was inversely associated with an adverse prognosis (p = 0.02). The medical treatment strategies only slightly improved the exercise time and the exercise duration remained of prognostic significance. In the revascularization group strategy patients this association was absent. Thus, myocardial ischemia detected by AECG and an abnormal ETT are each independently associated with an adverse cardiac outcome in patients subsequently treated medically.